Publications
71
Citations
1,853
Est. group size
—
Recurring co-author estimate
Active years
40
Publishing since 1987
Typically publishes in teams of ~4 · 44% small-team papers (≤3 authors) · across 11 venues
- Invited Commentary to “Reforming Surgical Graduate Medical Education Toward Accreditation Aligned with Readiness for Independent Practice” by Ellison, et al
Annals of Surgery · 2026
- Education Leadership in Accreditation Reform
JAMA · 2026
- Implementing the Promotion in Place Model of Competency-Based Time-Variable Graduate Medical Education in Pathology
Journal of Graduate Medical Education · 2025
- OS-059 Volixibat for the treatment of cholestatic pruritus in primary biliary cholangitis: an adaptive, randomized, placebo-controlled phase 2b trial (VANTAGE): 28-week interim results
Journal of Hepatology · 2025
- Addressing Socioeconomic Barriers to Residency Choice
New England Journal of Medicine · 2025
- In Reply to Cohn et al
Academic Medicine · 2025
- 784: VOLIXIBAT FOR THE TREATMENT OF CHOLESTATIC PRURITUS IN PRIMARY BILIARY CHOLANGITIS: AN ADAPTIVE, RANDOMIZED, PLACEBO-CONTROLLED PHASE 2B TRIAL (VANTAGE): INTERIM RESULTS
Gastroenterology · 2025
- Promotion in Place: A Model for Competency-Based, Time-Variable Graduate Medical Education
Academic Medicine · 2024
- Academic Medicine and Rural Health System Partnerships: Enhancing Education While Advancing Physician Workforce Priorities
Academic Medicine · 2024
- In the Eye of the Beholder: A Stakeholder Analysis of the Value of the “Promotion in Place” Competency-Based Time-Variable Graduate Medical Education Pilot
Academic Medicine · 2024
- Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE)
Open Forum Infectious Diseases · 2023
- Reengineering GME in a Pandemic — Looking Back, and Forward
New England Journal of Medicine · 2022
- ODP046 Initial Lessons from a Prescreening Protocol to Identify Participants with Classic CAH Potentially Eligible for Gene Therapy Treatment with BBP-631, an Adeno-associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human CYP21A2 Gene
Journal of the Endocrine Society · 2022
- Quiet, Yet Enormous, Steps Toward Gender Equity During COVID-19
Academic Medicine · 2022
- Medical Specialty Board Parental, Caregiver, and Medical Leave Policy Updates After 2021 American Board of Medical Specialties Mandate
JAMA · 2021
- Academic Medicine×13
- New England Journal of Medicine×6
- Journal of Graduate Medical Education×5
- JAMA×3
- Journal of General Internal Medicine×1
- Helen Morgan
Medicine · University of Michigan
- Avraham Z. Cooper
Medicine · The Ohio State University
- Maya M. Hammoud
Medicine · University of Michigan
- Joseph C. Kolars
Medicine · University of Michigan
- Robert D. Ficalora
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile